• linkedin
  • Increase Font
  • Sharebar

    November Clinical Considerations for NPs, PAs

    Joe Gorelick, MSN, FNP-CDear Colleagues,

    In this month’s Clinical Consideration, we focus on a few specific disorders and how to properly diagnose and treat them in our patients.

    Auxiliary hyperhidrosis is a challenging condition to manage effectively. These patients carry a severe psychosocial burden yet many go untreated. Increasing disease awareness and options for treatment may increase this patient populations willingness to seek treatment. To date, options for topical therapeutic agents are extremely limited yet DRM04 represents a novel and exciting topical option for providers and patients alike.

    How does your go-to regime for the treatment of Melasma stack up to the data? Melasma is frustrating condition for both patients and providers as it presents a true challenge to achieve and to deliver results. Recent research shows that the pathophysiology of melasma may be more complex that previously understood so a multifaceted approach may be needed to deliver optimal results. Read the insights of Dr. Grimes to see if your treatment is on par with the current literature and research.

    Finally, look for Syphilis! I know that I and many of our dermatology NP and PA colleagues around the country have made the diagnosis of both primary and secondary syphilis within the last year. This brief article is an excellent refresher on what to keep in mind so that we can make the diagnosis as it presents to our clinics.

    Best,

    Joe Gorelick, MSN, FNP-C, Dermatology Education Foundation Founder and Chairman

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow